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ABSTRACT
We compared the effect of set-up error and uncer-
tainty on two radiation therapy treatment plans for
head and neck cancer: one using intensity modulated
radiation therapy (IMRT) and one using conventional
three-dimensional conformal radiation therapy
(3D-CRT). We used a Pinnacle3 (Philips Medical Sys-
tems, Markham, Ontario) system to create the two
treatment plans (7-beam IMRT and 5-beam 3D-CRT)
for the same volumetric data set, based on the objec-
tives and constraints defined in the Radiation Therapy
Oncology Group H-0022 protocol. In both plans, the
dose–volume constraints for the targets and the or-
gans at risk (OARs) were met as closely as the beam
geometries would allow. Monte Carlo–based simu-
lations of set-up error and uncertainty were performed
in three orthogonal directions for 840 simulated
“courses of treatment” for each plan. A systematic
error (chosen from distributions characterized by stan-
dard deviations ranging from 0 mm to 6 mm) and
random uncertainties (2 mm standard deviation) were
incorporated. We used a probability approach to com-
pare the sensitivities of the IMRT and the 3D-CRT plans
to set-up error and uncertainty in terms of equivalent
uniform dose (EUD) to targets and OARs.
Based on the EUD analysis, the targets and OARs
showed considerably greater sensitivity to set-up error
with the IMRT plan than with the 3D-CRT plan. For the
IMRT plan, target EUDs were reduced by 4%, 7.5%, and
10% for 2-mm, 4-mm, and 6-mm set-up errors respec-
tively. However, even with set-up error, the mandible,
spinal cord, and parotid EUDs always remained lower
with the IMRT plan than with the 3D-CRT plan.
We conclude that, when quantified by EUD, IMRT-
plan doses to OARs and targets are more sensitive to
set-up error than are 3D-CRT-plan doses. However,
as judged by the differences between target and OAR
doses, IMRT retains its superiority over 3D-CRT, even
in the presence of set-up error.
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cancer, IMRT, 3D-CRT
1. INTRODUCTION
Treatment plan development and evaluation in head
and neck cancers are a challenge—in part because of
the large number of radiosensitive normal structures
in close proximity to the targets. The Radiation
Therapy Oncology Group (RTOG) designed a complex
protocol for cancer of the oropharynx (H-0022) 1 with
the main goal of exploring the feasibility and value
of delivering adequate target doses while sparing the
major salivary glands.
Intensity modulated radiation therapy (IMRT) is
available in many cancer centres and is becoming a
commonly used treatment procedure. In treatment-
plan generation, the dose distribution using IMRT has
been shown to be superior to that using three-dimen-
sional conformal radiation therapy (3D-CRT) 2. How-
ever, whether IMRT retains its superiority in the actual
clinical situation, where set-up error and uncertainty
are features of every treatment course, has not yet
been established.
In accord with reports 50 3 and 62 4 from the In-
ternational Commission on Radiation Units and Mea-
surements, margins are added to some of the volumes
of interest during the treatment planning process to
account for set-up error and uncertainty. For example,
to account for geometric uncertainties and organ mo-
tion, the clinical target volume (CTV), which encom-
passes the primary tumour and subclinical microscopic
disease, is extended by a margin to form the planning
target volume (PTV). For head and neck cancer, the
expansion of the CTV to a PTV accommodates set-up
error and geometric uncertainties, because organ mo-
tion and rotation are not significant for these sites 5.
Set-up error and uncertainty in treatment plan
evaluation are of considerable current interest 6–9, and
they are particularly relevant when highly conformal
plans are being considered. When treatment plans are
being created and optimized, the evaluation process
is almost always based on static volumes. Set-up
uncertainty is taken into consideration only through
generic margins on selected structures. Based on static
distributions, IMRT is considered by many to be a su-
perior technique 2. In the presence of set-up uncer-
tainty, the superiority of an IMRT plan may well be
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compromised; however, the degree of that uncertainty
is typically unknown.
To avoid ambiguity, we use the term “error” when
discussing systematic effects that influence an entire
course of treatment and the term “uncertainty” when
discussing random effects that influence individual
fractions. The rationale for this distinction is that sys-
tematic set-up errors are correctable, and protocols
exist for minimizing their magnitude 10–12.
Uncertainties are, by definition, not correctable.
However, the magnitude of the uncertainty can be
determined 10–12 and its effects taken into account
through the choice of margin around the CTV. Ran-
dom uncertainty quantifies interfraction and intra-
fraction geometric effects. With the advent of
image-guided radiation therapy (not considered in this
study), it may be possible to view interfraction ge-
ometry changes as correctable and therefore system-
atic on a fraction-by-fraction basis 13.
In this study, we compared two treatment plans
(one IMRT and one 3D-CRT) for a patient with head
and neck cancer. The anatomic contours were identi-
cal, and the two dose distributions were made as com-
parable as possible given the different beam
geometries. A Monte Carlo–based approach was used
to simulate set-up error and uncertainty through a
course of treatment.
2. METHODS
The two treatment plans were based on the objectives
and constraints defined in the RTOG H-0022 protocol 1.
The protocol specifies dose–volume objectives for
PTVs, but because CTVs were the structures of primary
clinical interest for us, our analysis considers the ef-
fect of set-up error and uncertainty on the CTVs. We
used Pinnacle3 software (Philips Medical Systems,
Markham, Ontario) to create both treatment plans on
the same set of contours.
The computed tomography (CT) volumetric data
set was acquired from a patient with a T2N0 squa-
mous-cell carcinoma of the right tonsil. The CT scans
were performed using an ACQSim simulator (Philips
Medical Systems) with a 3-mm slice thickness and
contiguous slices and were then contoured accord-
ing to the RTOG H-0022 protocol guidelines by the
radiation oncologist (HL). Contours were the CTV66,
CTV54, and organs at risk (OARs): spinal cord, brain-
stem, glottic larynx, right and left parotid glands, and
mandible. The CT data set, including contours, was
then exported to Pinnacle3 for treatment planning.
The IMRT treatment plan was developed accord-
ing to the RTOG protocol guidelines 1: 7-beam 6-MV
“step and shoot” plan, generated using Pinnacle3 (Fig-
ure 1). The beams were co-planar and were planned
for delivery at these gantry angles: 0, 51, 103, 154,
206, 257, and 309 degrees.
The 3D-CRT plan (Figure 2) was developed using
lateral parallel opposed fields and a matching low
anterior supraclavicular field with midline spinal-cord
shield. Spinal-cord blocking was introduced on the
lateral fields after 19 fractions, and the right and left
posterior neck areas were boosted for a further
13.2 Gy in 6 fractions using 12 MeV electrons, for a
total dose of 55 Gy in 25 fractions to the CTV54. The
CTV66 was treated to 66 Gy in 2.2 Gy fractions, for a
total of 30 fractions. The low anterior supraclavicu-
lar field was treated to 54 Gy in 30 fractions. Thus,
the CTV54 received a minimum dose of 54 Gy.
FIGURE 1 Intensity modulated radiation therapy (IMRT) treatment plan
showing the clinical target volumes CTV66, CTV54, and isodose lines
for 66 Gy, 54 Gy, and 35 Gy.
FIGURE 2 Three-dimensional conformal radiation therapy (3D-CRT)
treatment plan showing the clinical target volumes CTV66, CTV54,
and isodose lines for 66 Gy, 54 Gy, and 35 Gy.CURRENT ONCOLOGY—VOLUME 13, NUMBER 2
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For both plans, dose–volume histograms (DVHs)
for the two PTVs and the six OARs were matched as
closely as possible. All were designed to satisfy
H-0022 objectives and constraints. With the differ-
ent beam geometries and modalities (the 3D-CRT plan
required posterior neck electrons), our ability to make
the distributions similar was clearly limited. For our
analysis, the volumes of interest were the CTVs and
not the PTVs. The PTVs were used simply for planning
purposes. Figure 3 shows DVHs for the CTV54 and
CTV66 for both plans.
The convolution method has been shown to pos-
sibly be inappropriate for simulating geometric un-
certainties when structures of interest are close to the
surface 14. Our study was based on a more accurate,
and more resource-intensive, Monte Carlo–based
approach. Systematic errors (type B) and random
uncertainties (type A) 15 were both considered. Sys-
tematic errors are known to have a greater effect on
the dose distribution than random uncertainties of the
same magnitude have, especially for patients with
head and neck cancer 16.
In the present study, the standard deviation of the
random error was fixed at 2 mm, and the standard
deviation of the distribution of systematic errors for
a cohort of patients was varied from 0 mm to 6 mm
in increments of 1 mm. The relevant method was
described in detail in a previous paper by us 17 and
will be only briefly outlined here.
The first step was to use Pinnacle3 to compute
dose distributions in all three orthogonal directions
(anterior–posterior, lateral, superior–inferior) for
shifts from –10 mm to +10 mm in increments of
1 mm. Thus, 61 pre-calculated dose distributions were
obtained for each plan. Using this approach, we could
account both for surface contours and for internal
inhomogeneities as accurately as the algorithm per-
mitted. For any one course, the mean displacement
of the patient is represented by a single number, the
systematic error. For any one fraction within that
course, the displacement of the patient is chosen at
random from a Gaussian distribution (s = 2 mm) cen-
tered on the systematic error. The systematic error
for a particular course was chosen at random from a
Gaussian distribution intended to represent the dis-
tribution of systematic errors for a patient popula-
tion. For a group of patients, such as those being
simulated here, an a priori uncertainty exists regard-
ing the systematic displacement of any one patient.
However, once the treatment (or the computer simu-
lation of treatment) commences, this systematic ef-
fect is fixed and may be termed an “error” for that
particular patient. As previously noted, clinical pro-
tocols exist for correcting systematic effects in radia-
tion therapy 10–12.
We used a Monte Carlo–based simulation for
choosing the random displacement per fraction and
the systematic error for a course within Gaussian dis-
tributions of 2 mm standard deviation for random
uncertainties and 0 mm to 6 mm standard deviation
for systematic errors. From the interpolation between
the two closest of the 61 pre-calculated dose distri-
butions, we used the total shift to calculate the new
dose distribution. The simulations were run for
40 courses each for the two plans and for assigned
systematic error. We summed 30 dose distributions,
corresponding to one 30-fraction treatment course,
to obtain cumulative dose distributions and DVHs for
that simulated course.
We included both electron and photon contribu-
tions to the dose distribution in the DVH used to cal-
culate the equivalent uniform dose (EUD) described
below. Matching of photon and electron beams is a
well-known clinical issue for this type of treatment.
Our approach was based on the expertise of our
dosimetrists, who generated treatment plans that were
consistent with our usual practice and that met with
the approval of the responsible radiation oncologist.
Variability in the location of the electron fields
with respect to the photon fields was not simulated.
FIGURE 3 Dose–volume histograms for the clinical target volumes CTV66/54 in the static situation for the intensity modulated radiation
therapy (IMRT) plan (solid line) and the three-dimensional conformal radiation therapy (3D-CRT) plan (dashed line).64
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It was assumed that these abutting fields were cor-
rectly positioned with respect to each other through-
out the course. Thus only patient positioning effects
were considered.
The concept of the generalized EUD was intro-
duced by Niemerko 18 in the late 1990s as a means
for condensing the two-dimensional DVH into one
number. The EUD corresponds to “the homogeneous
dose distribution which produces the same surviving
fraction of clonogenic cells as that obtained with an
inhomogeneous dose distribution.” Specifically:
N
EUD = (åvi
 · D
a
i)
1/a
,
i=1
where N is the number of voxels, vi and Di are re-
spectively the fractional volume and the dose at that
volume, and a is a volume exponent that depends on
the structure of interest. Through the a value, the EUD
attempts to reflect the biologic significance of a non-
uniform dose distribution in the targets and the OARs
alike. The EUD for a target will emphasize low-dose
regions and de-emphasize high-dose regions.
We recently introduced the concept of EUD5%
which is calculated from the spread of EUD values
calculated from the 40 (in our case) simulated treat-
ment courses. The EUD5% is the EUD value below
which 5% of the treatment courses are estimated to
fall for a target and above which 5% of the treat-
ment courses are estimated to fall for an OAR 17. The
spread of EUD values are Gaussian-fitted to render a
statistical EUD value that has a probability of 0.05.
This probability-based approach makes it easy to
summarize the results of multiple Monte Carlo simu-
lations corresponding to the treatment of a cohort
of patients.
3. RESULTS
We performed 1680 treatment-course simulations
(840 for IMRT and 840 for 3D-CRT) in the three or-
thogonal directions for seven distributions of system-
atic error ranging from 0 mm to 6 mm standard
deviation.
Figures 1 and 2 show the dose distributions of
the IMRT and 3D-CRT plans respectively. Superior
conformality of the dose to the tumour for the IMRT
plan is clear from Figure 1.
Figure 3 shows the DVHs of the CTV54 and CTV66
for both the IMRT plan and the 3D-CRT plan.
Figure 4 shows the EUD5% of the two targets and
the six OARs in the static situation and in the presence
of set-up error and uncertainty. The EUD5% on the his-
tograms corresponds to the average EUD5% over the
three orthogonal directions studied in the simulations.
For clarity, we present the results for the static situa-
tion and for the 2 mm, 4 mm, and 6 mm standard
deviations only.
4. DISCUSSION
Evaluation of a treatment plan using DVH data alone
may be inadequate. On Figure 3, the DVHs are seen to
cross, and concluding which treatment technique
gives the better dose distribution is difficult. Exam-
ining the EUD together with the DVH and the 3D dose
distribution assists in identifying the optimum plan.
In the static situation, the EUD5% to the CTV66 in
the IMRT plan is slightly higher than the EUD5% to the
CTV66 in the 3D-CRT plan, although both have the same
isocentre dose. Interestingly, the EUD5% to the CTV54
is lower in the IMRT plan because of the irregular shape
of the CTV54 and the difference in the geometric con-
figuration of the beams for the two plans. The EUD5%
to the brainstem and the glottic larynx show no sig-
nificant differences. The real benefits of the IMRT plan
over the 3D-CRT plan, quantified in terms of EUD, ac-
crue to the spinal cord (12.6% reduction in EUD5%),
the mandible (13.8% reduction in EUD5%), the left
parotid (32.2% reduction in EUD5%), and the right
parotid (35.5% reduction in EUD5%). Parotid sparing
is the principal objective of the RTOG protocol and is
clearly achieved with this IMRT plan in the static
situation.
Figure 4 also shows the variation in the EUD5%
for the eight structures when set-up error and uncer-
tainty are incorporated into the treatment plans. As
set-up error increases from 0 mm to 6 mm, the EUD5%
to the CTV66 and CTV54 decline and the EUD5% to the
OARs rise in both plans, but by different amounts. For
example, the EUD5% to CTV66 in the static situation for
the IMRT plan is 69.8 Gy. In the presence of a 2-mm
standard deviation in systematic error, this EUD5%
drops to 66.8 Gy. Set-up error on CTV54 for 3D-CRT
can be seen to have little effect. Indeed, the EUD is
reduced by less than 1% for a 6-mm systematic set-
up error.
From Figure 4, we also observe that sensitivity
to set-up error and uncertainty is greater in the IMRT
plan than in the 3D-CRT plan for the targets and all six
OARs. However, when a patient is treated with 3D-CRT,
the target will likely receive an adequate dose even
in presence of set-up uncertainties. Particularly, lat-
eral shifts on the 3D-CRT will have very little impact
on the CTV66/54 because the treatment uses parallel
opposed beams. However, IMRT retains its overall
superiority with respect to the difference between
doses to the target and the OARs. In particular, even in
the presence of large set-up error, the EUD5% values in
the IMRT plan are 27% lower for the right parotid and
29% lower for the left parotid than they are in the
3D-CRT plan. Thus set-up error, within the range ex-
amined, does not compromise the parotid gland–spar-
ing capability of IMRT.
The EUD5% equation used in this study does not
take into account dose-per-fraction effects. The only
structure considered to be of relevance in this regard
is the spinal cord, which, in the 3D-CRT approach, isCURRENT ONCOLOGY—VOLUME 13, NUMBER 2
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blocked after 19 fractions. To account for this factor,
we calculated the equivalent uniform biologically
effective dose (EUBED) 19 for the spinal cord,
EUBED (Gy) = EUD (Gy) · æ1 +  eudö ,
èa /bø
where EUD is the total EUD received by the spinal cord
in grays, eud is the EUD per fraction in grays, and the
ratio a/b (the dose at which the linear and quadratic
components of the radiation damage are equal) is 3 Gy
for the spinal cord 20. This calculation is an attempt
to normalize the larger fraction size to the spinal cord
in the 3D-CRT plan with respect to the equivalent in
the IMRT plan in terms of biologic effect. The EUBED
for the spinal cord in the static situation was 45.6 Gy
(EUD = 33.8 Gy) for the IMRT plan and 65.0 Gy (EUD =
38.7 Gy) for the 3D-CRT plan. Thus, for the particu-
lar case of the spinal cord, which is blocked after
19 fractions in the 3D-CRT plan, increased superior-
ity in the IMRT plan is demonstrated when fraction
size is taken into account. Adjusting for the different
fraction size, the EUBED to the spinal cord is 28% lower
in the IMRT plan.
Set-up error and uncertainty can lower the dose
to the targets while the dose to the OARs increases.
However, the original EUD of the target can be re-
stored simply by increasing the isocentre dose by the
fractional amount of EUD lost in the presence of set-
up uncertainty. This change will, of course, increase
the dose to the OARs. However, based on our results,
even with an increase in the isocentre dose necessary
to restore the target EUD, the EUDs to the OARs—and
especially the parotid glands, the main structures of
interest in this study—will remain well below the dose
reached in the 3D-CRT plan. An opportunity there-
fore exists either to increase the target dose to restore
the EUDs of the OARs to their static values or to main-
tain the target EUD at its static value and to provide
greater protection to the OARs. The EUD formalism
lends itself to this sort of approach because EUDs scale
linearly with dose.
5. CONCLUSION
We have shown that set-up error and uncertainty in
the clinical situation have an impact on the EUDs re-
ceived by the targets and by the critical structures in
both IMRT and 3D-CRT head and neck treatment plans.
Even though the effect is more noticeable with IMRT,
the IMRT treatment technique retains its superiority over
3D-CRT in presence of set-up error and uncertainty.
After accounting for the effects of fraction size on the
EUD to the spinal cord, that structure is seen to receive
additional sparing because of the lower dose per frac-
tion of IMRT. Finally, the EUD approach lends itself to
compensation for patient positioning effects, if re-
quired. All EUDs scale to the dose at any point. Thus,
FIGURE 4 The 5% equivalent uniform dose (EUD5%) to the two targets (clinical target volumes CTV54 and CTV66) and six organs at risk (OARs)
in the static situation (black) and in presence of systematic set-up error. Random uncertainty was fixed at 2 mm standard deviation. The
EUD5% is the EUD value below which 5% of the treatment courses are estimated to fall for a target and above which 5% of the treatment courses
are estimated to fall for an OAR.66
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the effect of an increase (or decrease) of the isocentre
dose can be immediately calculated for the target and
OAR EUDs, permitting an estimate of the probability
that a treatment course will achieve given EUDs.
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